MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
263.40
-3.84
-1.44%
After Hours: 264.20 +0.8 +0.30% 17:03 07/08 EDT
OPEN
268.60
PREV CLOSE
267.24
HIGH
268.60
LOW
263.13
VOLUME
6.71M
TURNOVER
--
52 WEEK HIGH
269.43
52 WEEK LOW
150.45
MARKET CAP
634.06B
P/E (TTM)
30.47
1D
5D
1M
3M
1Y
5Y
1D
A New Look At Legend Biotech: Plenty Of Upside For Carvykti
Seeking Alpha · 10h ago
Best ETFs to Invest In, According to AI Analyst, 7/8/2026
TipRanks · 10h ago
Compass Pathways: 'Strong Buy' COMP360 Trial Wins And Q4 NDA Full Submission
Seeking Alpha · 11h ago
Johnson & Johnson Is Maintained at Overweight by Morgan Stanley
Dow Jones · 11h ago
Morgan Stanley Maintains Overweight on Johnson & Johnson, Raises Price Target to $284
Benzinga · 11h ago
Johnson & Johnson Is Maintained at Buy by Citigroup
Dow Jones · 12h ago
Johnson & Johnson Price Target Raised to $298.00/Share From $285.00 by Citigroup
Dow Jones · 12h ago
Citigroup Maintains Buy on Johnson & Johnson, Raises Price Target to $298
Benzinga · 13h ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.